ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

7 links1 made here, not in the record8 judgments2 judges (the rules as one: Rule based)0 record changes seen
Claude Opus 5.5Rule basedMade here
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT06494345A Study of Genolair in TwoDosage Forms (Solution andLyophilisate) and Xolair®in Healthy VolunteersAO GENERIUMPhase 1 · completedRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSRhinitis, AllergicThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termAs of now · Rule based · Main conditionMain conditionBronchial DiseasesThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termRespiratory Tract DiseasesThe registry's MeSH filing›Nov 14 · Rule based · General: a category, not a diseaseGeneral: a category, not a diseaseLung DiseasesThe registry's MeSH filing›Nov 14 · Rule based · General: a category, not a diseaseGeneral: a category, not a diseaseRespiratory HypersensitivityThe registry's MeSH filing›Nov 14 · Rule based · Wider: a narrower term is filedWider: a narrower term is filedImmune System DiseasesThe registry's MeSH filing›Nov 14 · Rule based · General: a category, not a diseaseGeneral: a category, not a diseaseDRUGSOmalizumabMade here · Found by reading; no entr…›Nov 4 · Claude Opus 5.5 · ComparatorComparator

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Omalizumab

Made here1 judgment on this link
NCT06494345gives it, found by reading the recordOmalizumabDefined by Claude Opus 5.5Nov 4, 2026, 8:28 AM UTC
Role in the study, from the registry to what was judged
RegistryNot in the recordno intervention entry names it
→judged

All judgments on this study

WhenLinkJudgeDecisionState
Nov 4Omalizumabmade hereClaude Opus 5.5ComparatorCurrent
Nov 14Rhinitis, AllergicRule based · condition-kind ruleFinest filed termCurrent
Nov 14Bronchial DiseasesRule based · condition-kind ruleFinest filed termCurrent
Nov 14Respiratory Tract DiseasesRule based · condition-kind ruleGeneral: a category, not a diseaseCurrent
Nov 14Lung DiseasesRule based · condition-kind ruleGeneral: a category, not a diseaseCurrent
Nov 14Respiratory HypersensitivityRule based · condition-kind ruleWider: a narrower term is filedCurrent
Nov 14Immune System DiseasesRule based · condition-kind ruleGeneral: a category, not a diseaseCurrent
As of nowRhinitis, AllergicRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.

How a condition link is counted

For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.

A decision on file for one study overrides it, with who made it and when.